Intrinsic Value of S&P & Nasdaq Contact Us

MaxCyte, Inc. MXCT NASDAQ

NASDAQ Global Select • Healthcare • Medical - Devices • US • USD

SharesGrow Score
48/100
3/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$6.00
+609.9%

MaxCyte, Inc. (MXCT) has 20 known insider and institutional holders on record. The largest holder is Casdin Eli with 10,000,000 shares. Other notable holders include Casdin Partners Master Fund, L.P. and Sumen Cenk.

Over the last 12 months, insiders have made 16 transactions in MXCT stock — 14 buys (valued at $1.02M) and 2 sells (valued at $30.64K). Insider buying has outpaced selling during this period, which may signal confidence in the company's prospects.

MXCT Insider Ownership

Top Holder
Casdin Eli
10,000,000 shares
Buys (12 mo)
14
$1.02M value
Sells (12 mo)
2
$30.64K value
12-Month Transaction Activity
Buy 88%
Sell 13%
Top Insider Holders
# Name Role Shares Owned Last Filed Relative Size
1 Casdin Eli Director 10,000,000 2022-10-05
100%
2 Casdin Partners Master Fund, L.p. 10 Percent Owner 10,000,000 2022-10-05
100%
3 Sumen Cenk Chief Scientific Officer 500,000 2023-03-21
5%
4 Masoud Maher President and CEO 475,000 2026-03-31
5%
5 Erck Stanley C Director 398,328 2025-08-13
4%
6 Douglas Richard Director 230,577 2025-08-13
2%
7 Doerfler Douglas President and CEO 184,522 2023-12-06
2%
8 Swirsky Douglas J Chief Financial Officer 151,669 2026-03-19
2%
9 Brooke William W Director 150,879 2025-08-13
2%
10 Murphy Amanda Louise Chief Financial Officer 142,000 2022-03-29
1%
11 Holtz Ron Chief Financial Officer 120,000 2023-03-21
1%
12 Sandoval David I. General Counsel 64,219 2025-03-20
1%
13 Soleymannezhad Ali Chief Commercial Officer 59,439 2025-03-20
1%
14 Johnston John Joseph Director 50,790 2025-06-23
1%
15 Collins Cynthia Director 50,790 2025-06-23
1%
16 Al-wakeel Yasir B. Director 50,577 2025-06-23
1%
17 Balthrop Patrick J Director 50,577 2025-06-23
1%
18 Mandell Art Director 40,701 2024-06-13
0%
19 Hemrajani Rekha Director 39,893 2025-08-27
0%
20 Ross Thomas M. EVP, Global Sales 17,858 2024-08-05
0%
Recent Transactions (last 12 months)
Date Name Role Type Shares Price Value
2026-03-27 Masoud Maher President and CEO RSU Award 300,000 - -
2026-03-17 Swirsky Douglas J Chief Financial Officer Informative Sell 10,142 $0.82 $8.27K
2025-06-25 Hemrajani Rekha Director Informative Sell 10,684 $2.09 $22.38K
2025-08-13 Masoud Maher President and CEO Informative Buy 75,000 $1.37 $102.92K
2025-08-13 Brooke William W Director Informative Buy 50,000 $1.29 $64.5K
2025-08-13 Swirsky Douglas J Chief Financial Officer Informative Buy 50,000 $1.29 $64.5K
2025-08-13 Erck Stanley C Director Informative Buy 100,000 $1.37 $137.22K
2025-08-13 Douglas Richard Director Informative Buy 80,000 $1.39 $111.04K
2025-06-18 Johnston John Joseph Director RSU Award 50,790 $2.11 $107.17K
2025-06-18 Hemrajani Rekha Director RSU Award 29,210 - -
2025-06-18 Al-wakeel Yasir B. Director RSU Award 29,210 - -
2025-06-18 Brooke William W Director RSU Award 50,790 $2.11 $107.17K
2025-06-18 Collins Cynthia Director RSU Award 50,790 $2.11 $107.17K
2025-06-18 Erck Stanley C Director RSU Award 50,790 $2.11 $107.17K
2025-06-18 Balthrop Patrick J Director RSU Award 29,210 - -
2025-06-18 Douglas Richard Director RSU Award 50,790 $2.11 $107.17K
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message